Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 15.92
- Piotroski Score 7.00
- Grade Overweight
- Symbol (PEN)
- Company Penumbra, Inc.
- Price $233.08
- Changes Percentage (-0.27%)
- Change -$0.62
- Day Low $232.92
- Day High $239.99
- Year High $277.34
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/25/2025
- Fiscal Year End N/A
- Average Stock Price Target $235.00
- High Stock Price Target $285.00
- Low Stock Price Target $150.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $2.38
- Trailing P/E Ratio 79.39
- Forward P/E Ratio 79.39
- P/E Growth 79.39
- Net Income $90.95 M
Income Statement
Quarterly
Annual
Latest News of PEN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Matthew DeSoto Spends US$543k On Mid Penn Bancorp Stock
Matthew DeSoto, Independent Director of Mid Penn Bancorp, recently bought US$543k worth of company shares at an average price of US$29.50. This insider purchase, the largest in the past year, signals ...
By Yahoo! Finance | 19 hours ago -
Blue Jays free-agent fits: Which relievers can help rebuild Toronto's bullpen?
The Toronto Blue Jays are focused on improving their offense and rebuilding their bullpen in the offseason. They aim to acquire relievers who excel in late-inning situations to address their bullpen's...
By The New York Times | 20 hours ago -
How Max Verstappen can win the drivers' championship in Las Vegas and light up F1's glitziest race
The article discusses Max Verstappen's remarkable win at the Sao Paulo Grand Prix, putting him close to clinching his fourth world championship....
By The New York Times | 20 hours ago
